Orfenix combines the symbolism of the phoenix, renewal, transformation, and the concept of an orphan drug, focus on rare diseases. It represents a company committed to innovative, responsible drug development, inspired by Orpheus’ healing and artistry.
At Orfenix, we transform existing compounds into new, affordable therapies.
Our subject matter experts collaborate with leading academics and partners to bring innovative treatments from the lab to the patient.
Each project brings together the best minds, ensuring we address every challenge with expertise and passion.
Our specialized, agile team stays cost-efficient and responsive, driving forward life-changing projects.
We believe in making treatments accessible to all, adhering to principles of social responsibility and equity.
Vincent van der Wel
Founder & Director
Ivo de Nooijer
Partner & Director
Meet the Orfenix team —driven by a passion for responsible, innovative treatments for rare diseases.
Hellen Houlleberghs
Clinical Development Director
Barbara van den Aarsen
Director of Clinical Operations
& Regulatory
Willemijn Heinen
Graduate Intern
At Orfenix, we prioritize Collaboration, partnering with top academics, investors, and companies to bring innovative treatments from the lab to patients. By Repurposing existing compounds, we find new uses that address specific patient needs, while our commitment to Sustainable Development minimizes waste and reduces costs. We ensure Equitable Access through socially responsible licensing, and value Transparency and Trust in all operations, building strong relationships with patients and partners.
Do you want to make an impact on patients’ lives?
At Orfenix, you work with top professionals and collaborate with leading experts to bring forgotten treatments from the lab to patients.
If you’re passionate about transforming healthcare and thrive in a transparent, trust-driven environment, Orfenix is the place for you.